Business Segments and Geographical Information

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Business Segments and Geographical Information

17. Business Segments and Geographical Information

We operate in one segment, ophthalmology. Substantially all of our long-term assets are located in the U.S. We develop, manufacture and market medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service and support activities.

Revenue information shown by product is as follows (in thousands):

	FY 2022		FY 2021
	Year Ended		Year Ended
	December 31, 2022		January 1, 2022
Cyclo G6	$	14,694	$	13,950
Retina		31,657		31,106
Other(1)		10,621		8,847
Total revenues	$	56,972	$	53,903

(1) Includes service contract revenues of $1,509 thousand and $1,386 thousand recognized during fiscal years 2022 and 2021, respectively. Includes $1,348 thousand and $615 thousand recognized revenue related to the exclusive distribution rights during fiscal years 2022 and 2021. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region is as follows (in thousands):

	FY 2022		FY 2021
	Year Ended		Year Ended
	December 31, 2022		January 1, 2022
United States	$	29,179	$	24,946
Europe, Middle East and Africa		13,801		13,970
Asia/Pacific Rim		10,931		12,444
Americas, excluding the U.S.		3,061		2,543
	$	56,972	$	53,903

Revenues are attributed to countries based on location of end customers.

Other than the United States, The Netherlands accounted for more than 10% of the Company’s revenues during fiscal year 2022, representing 11.8%. The United States accounted for 51.2% of revenues in 2022. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during fiscal year 2021, representing 13.5%. The United States accounted for 46.3% of revenues in 2021.